Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Sex and gender issues in multiple sclerosis.
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Iron and multiple sclerosis.
Effect of treadmill training on fatigue in multiple sclerosis: a pilot study.
Stem cell therapy independent of stemness.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders.
A confusing case of multiple sclerosis and central nervous system graft versus host disease.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Olfactory bulb and olfactory sulcus depths are associated with disease duration and attack frequency in multiple sclerosis patients.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study.
Modifiable environmental factors in multiple sclerosis.
IL2RA Allele Increases Risk of Neuromyelitis Optica in Southern Han Chinese.
The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases.
Baló's concentric sclerosis: imaging findings and pathological correlation.
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
441
442
443
444
445
446
447
448
449
…
next ›
last »